Davis Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$515K	Sell	4,023 -596	-13%	-$76.3K	0.18%	106
2025 Q1	$438K	Buy	+4,619	New	+$438K	0.19%	105